Increased activities of both superoxide dismutase and catalase were indicators of acute depressive episodes in patients with major depressive disorder

Psychiatry Research

Volumn 235, Issue , 2015, Pages 38-42

  Tsai, Meng Chang ^a   Huang, Tiao Lai ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

CAT; Depression; S100B; SOD

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; AGOMELATINE; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; CARBONYL DERIVATIVE; CATALASE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; GLUTATHIONE PEROXIDASE; MIRTAZAPINE; PAROXETINE; PROTEIN CARBONYL CONTENT; PROTEIN S100B; QUETIAPINE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRAZODONE; UNCLASSIFIED DRUG; VENLAFAXINE; 8-OXO-7-HYDRODEOXYGUANOSINE; BIOLOGICAL MARKER; DEOXYGUANOSINE; S100B PROTEIN, HUMAN;

ACUTE DISEASE; ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG RESPONSE; ENZYME ACTIVITY; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; LENGTH OF STAY; LIPID PEROXIDATION; MAJOR DEPRESSION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; REMISSION; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; ENZYMOLOGY; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; PHYSIOLOGY; PROTEIN CARBONYLATION;

ADULT; BIOMARKERS; CASE-CONTROL STUDIES; CATALASE; DEOXYGUANOSINE; DEPRESSIVE DISORDER, MAJOR; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84949654751     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2015.12.005     Document Type: Article

References (53)

1. Aguiar C.C., Almeida A.B., Araujo P.V., Vasconcelos G.S., Chaves E.M., do Vale O.C., Macedo D.S., Leal L.K., de Barros Viana G.S., Vasconcelos S.M. Effects of agomelatine on oxidative stress in the brain of mice after chemically induced seizures. Cell. Mol. Neurobiol. 2013, 33(6):825-835.
2. Akdemir A., Turkcapar M.H., Orsel S.D., Demirergi N., Dag I., Ozbay M.H. Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale. Compr. Psychiatry 2001, 42(2):161-165.
3. Arolt V., Peters M., Erfurth A., Wiesmann M., Missler U., Rudolf S., Kirchner H., Rothermundt M. S100B and response to treatment in major depression: a pilot study. Eur. Neuropsychopharmacol. 2003, 13(4):235-239.
4. Battal D., Yalin S., Eker E.D., Aktas A., Sahin N.O., Cebo M., Berkoz M. Possible role of selective serotonin reuptake inhibitor sertraline on oxidative stress responses. Eur. Rev. Med. Pharmacol. Sci. 2014, 18(4):477-484.
5. Berg D., Youdim M.B., Riederer P. Redox imbalance. Cell. Tissue Res. 2004, 318(1):201-213.
6. Bhabak K.P., Mugesh G. Functional mimics of glutathione peroxidase: bioinspired synthetic antioxidants. Acc. Chem. Res. 2010, 43(11):1408-1419.
7. Bilici M., Efe H., Koroglu M.A., Uydu H.A., Bekaroglu M., Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J. Affect. Disord. 2001, 64(1):43-51.
8. Black C.N., Bot M., Scheffer P.G., Cuijpers P., Penninx B.W. Is depression associated with increased oxidative stress? A systematic review and meta-analysis. Psychoneuroendocrinology 2015, 51:164-175.
9. Bloomfield S.M., McKinney J., Smith L., Brisman J. Reliability of S100B in predicting severity of central nervous system injury. Neurocrit. Care 2007, 6(2):121-138.
10. Che Y., Wang J.F., Shao L., Young T. Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. J. Psychiatry Neurosci. 2010, 35(5):296-302.
11. Chelikani P., Fita I., Loewen P.C. Diversity of structures and properties among catalases. Cell. Mol. Life Sci. 2004, 61(2):192-208.
12. Chung C.P., Schmidt D., Stein C.M., Morrow J.D., Salomon R.M. Increased oxidative stress in patients with depression and its relationship to treatment. Psychiatry Res. 2013, 206(2-3):213-216.
13. Dringen R., Pawlowski P.G., Hirrlinger J. Peroxide detoxification by brain cells. J. Neurosci. Res. 2005, 79(1-2):157-165.
14. Faizal P., Satheeshan B., Milindkumar, Adarsh A.K., Shilpa R., Roshni P., Remya T., Augusti K.T. Antioxidant status and oxidative stress in the circulation of younger and elderly human subjects. Indian J. Clin. Biochem. 2013, 28(4):426-428.
15. Filomeni G., Ciriolo M.R. Redox control of apoptosis: an update. Antioxid. Redox Signal 2006, 8(11-12):2187-2192.
16. Forlenza M.J., Miller G.E. Increased serum levels of 8-hydroxy-2'-deoxyguanosine in clinical depression. Psychosom. Med. 2006, 68(1):1-7.
17. Galecki P., Kedziora J., Florkowski A., Galecka E. [Lipid peroxidation and copper-zinc superoxide dismutase activity in patients treated with fluoxetine during the first episode of depression]. Psychiatr. Pol. 2007, 41(5):615-624.
18. Galecki P., Szemraj J., Bienkiewicz M., Florkowski A., Galecka E. Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment. Pharmacol. Rep. 2009, 61(3):436-447.
19. Grabe H.J., Ahrens N., Rose H.J., Kessler C., Freyberger H.J. Neurotrophic factor S100 beta in major depression. Neuropsychobiology 2001, 44(2):88-90.
20. Halliwell B. Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiol. 2006, 141(2):312-322.
21. Halliwell B. Biochemistry of oxidative stress. Biochem. Soc. Trans. 2007, 35(Pt 5):1147-1150.
22. Herken H., Gurel A., Selek S., Armutcu F., Ozen M.E., Bulut M., Kap O., Yumru M., Savas H.A., Akyol O. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch. Med. Res. 2007, 38(2):247-252.
23. Jang B.S., Kim H., Lim S.W., Jang K.W., Kim D.K. Serum S100B Levels and Major Depressive Disorder: Its Characteristics and Role in Antidepressant Response. Psychiatry Investig. 2008, 5(3):193-198.
24. Jorgensen A., Krogh J., Miskowiak K., Bolwig T.G., Kessing L.V., Fink-Jensen A., Nordentoft M., Henriksen T., Weimann A., Poulsen H.E., Jorgensen M.B. Systemic oxidatively generated DNA/RNA damage in clinical depression: associations to symptom severity and response to electroconvulsive therapy. J. Affect. Disord. 2013, 149(1-3):355-362.
25. Khanzode S.D., Dakhale G.N., Khanzode S.S., Saoji A., Palasodkar R. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep. 2003, 8(6):365-370.
26. Kim J.K., Kim S.G., Kim H.J., Song Y.R. Serum S100B protein is associated with depressive symptoms in patients with end-stage renal disease. Clin. Biochem. 2012, 45(18):1573-1577.
27. Kodydkova J., Vavrova L., Zeman M., Jirak R., Macasek J., Stankova B., Tvrzicka E., Zak A. Antioxidative enzymes and increased oxidative stress in depressive women. Clin. Biochem. 2009, 42(13-14):1368-1374.
28. Kokacya M.H., Bahceci B., Bahceci I., Dilek A.R., Dokuyucu R. Prolidase activity and oxidative stress in patients with major depressive disorder. Psychiatr. Danub. 2014, 26(4):314-318.
29. Kotan V.O., Sarandol E., Kirhan E., Ozkaya G., Kirli S. Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35(5):1284-1290.
30. Lopresti A.L., Maker G.L., Hood S.D., Drummond P.D. A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers. Prog. Neuropsychopharmacol. Biol. Psychiatry 2014, 48:102-111.
31. Lukic I., Mitic M., Djordjevic J., Tatalovic N., Bozovic N., Soldatovic I., Mihaljevic M., Pavlovic Z., Radojcic M.B., Maric N.P., Adzic M. Lymphocyte levels of redox-sensitive transcription factors and antioxidative enzymes as indicators of pro-oxidative state in depressive patients. Neuropsychobiology 2014, 70(1):1-9.
32. Lushchak V.I. Free radicals, reactive oxygen species, oxidative stress and its classification. Chem. Biol. Interact. 2014, 224C:164-175.
33. Maes M., Galecki P., Chang Y.S., Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35(3):676-692.
34. Maes M., Kubera M., Leunis J.C., Berk M., Geffard M., Bosmans E. In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes. Acta Psychiatr. Scand. 2013, 127(5):344-354.
35. Maes M., Mihaylova I., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E. Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis/chronic fatigue syndrome. Neuro Endocrinol. Lett. 2009, 30(6):715-722.
36. Magalhaes P.V., Jansen K., Pinheiro R.T., Colpo G.D., da Motta L.L., Klamt F., da Silva R.A., Kapczinski F. Peripheral oxidative damage in early-stage mood disorders: a nested population-based case-control study. Int. J. Neuropsychopharmacol. 2012, 15(8):1043-1050.
37. Moylan S., Berk M., Dean O.M., Samuni Y., Williams L.J., O'Neil A., Hayley A.C., Pasco J.A., Anderson G., Jacka F.N., Maes M. Oxidative & nitrosative stress in depression: why so much stress?. Neurosci. Biobehav. Rev. 2014, 45:46-62.
38. Niki E. Biomarkers of lipid peroxidation in clinical material. Biochim. Biophys. Acta 2014, 1840(2):809-817.
39. Ormonde do Carmo M.B., Mendes-Ribeiro A.C., Matsuura C., Pinto V.L., Mury W.V., Pinto N.O., Moss M.B., Ferraz M.R., Brunini T.M. Major depression induces oxidative stress and platelet hyperaggregability. J. Psychiatr. Res. 2015, 61:19-24.
40. Parikh V., Khan M.M., Mahadik S.P. Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. J. Psychiatr. Res. 2003, 37(1):43-51.
41. Rybka J., Kedziora-Kornatowska K., Banas-Lezanska P., Majsterek I., Carvalho L.A., Cattaneo A., Anacker C., Kedziora J. Interplay between the pro-oxidant and antioxidant systems and proinflammatory cytokine levels, in relation to iron metabolism and the erythron in depression. Free Radic. Biol. Med. 2013, 63:187-194.
42. Sabens Liedhegner E.A., Gao X.H., Mieyal J.J. Mechanisms of altered redox regulation in neurodegenerative diseases - focus on S-glutathionylation. Antioxid. Redox Signal 2012, 16(6):543-566.
43. Sarandol A., Sarandol E., Eker S.S., Erdinc S., Vatansever E., Kirli S. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum. Psychopharmacol. 2007, 22(2):67-73.
44. Serpero L.D., Bellissima V., Colivicchi M., Sabatini M., Frigiola A., Ricotti A., Ghiglione V., Strozzi M.C., Li Volti G., Galvano F., Gazzolo D. Next generation biomarkers for brain injury. J. Matern. Fetal Neonatal Med. 2013, 26(Suppl. 2):S44-S49.
45. Spanemberg L., Caldieraro M.A., Vares E.A., Wollenhaupt-Aguiar B., Kauer-Sant'Anna M., Kawamoto S.Y., Galvao E., Parker G., Fleck M.P. Biological differences between melancholic and nonmelancholic depression subtyped by the CORE measure. Neuropsychiatr. Dis. Treat. 2014, 10:1523-1531.
46. Stefanescu C., Ciobica A. The relevance of oxidative stress status in first episode and recurrent depression. J. Affect. Disord. 2012, 143(1-3):34-38.
47. Szebeni A., Szebeni K., DiPeri T., Chandley M.J., Crawford J.D., Stockmeier C.A., Ordway G.A. Shortened telomere length in white matter oligodendrocytes in major depression: potential role of oxidative stress. Int. J. Neuropsychopharmacol. 2014, 17(10):1579-1589.
48. Szuster-Ciesielska A., Slotwinska M., Stachura A., Marmurowska-Michalowska H., Dubas-Slemp H., Bojarska-Junak A., Kandefer-Szerszen M. Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32(3):686-694.
49. Vassalle C., Novembrino C., Maffei S., Sciarrino R., De Giuseppe R., Vigna L., de Liso F., Mercuri A., Bamonti F. Determinants of oxidative stress related to gender: relevance of age and smoking habit. Clin. Chem. Lab. Med. 2011, 49(9):1509-1513.
50. Wiener C., Rassier G.T., Kaster M.P., Jansen K., Pinheiro R.T., Klamt F., Magalhaes P.V., Kapczinski F., Ghisleni G., da Silva R.A. Gender-based differences in oxidative stress parameters do not underlie the differences in mood disorders susceptibility between sexes. Eur. Psychiatry 2014, 29(1):58-63.
51. Winterbourn C.C. Superoxide as an intracellular radical sink. Free Radic. Biol. Med. 1993, 14(1):85-90.
52. Xu Y., Wang C., Klabnik J.J., O'Donnell J.M. Novel therapeutic targets in depression and anxiety: antioxidants as a candidate treatment. Curr. Neuropharmacol. 2014, 12(2):108-119.
53. Yager S., Forlenza M.J., Miller G.E. Depression and oxidative damage to lipids. Psychoneuroendocrinology 2010, 35(9):1356-1362.